REGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALS

REGENERON PHARMACEUTICALS

No trades
See on Supercharts

4REGN fundamentals

REGENERON PHARMACEUTICALS earnings per share and revenue

4REGN earnings per share for the last quarter are 11.19 EUR whereas the estimation was 10.50 EUR which accounts for 6.54% surprise. Company revenue for the same period amounts to 3.34 B EUR despite the estimated figure of 3.30 B EUR. Estimated earnings per share for the next quarter are 10.86 EUR, and revenue is expected to reach 3.62 B EUR. Also watch annual changes over time to get a bigger picture of 4REGN earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise